(Q34249374)

31 July 2017

title

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma (English)

1 reference

31 July 2017

Raoul Orvieto

1

1 reference

31 July 2017

publication date

5 November 2013

1 reference

Journal of Ovarian Research

31 July 2017

published in

1 reference

31 July 2017

volume

6

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

77

1 reference

https://scigraph.springernature.com/pub.10.1186/1757-2215-6-77

31 July 2017

exact match

0 references

cites work

Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176292

GnRH agonist triggering: recent developments.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176292

The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176292

An OHSS-Free Clinic by segmentation of IVF treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176292

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicent

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176292

Substituting HCG with GnRH agonist to trigger final follicular maturation--a retrospective comparison of three different ovarian stimulation protocols.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176292

Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176292

GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176292

Can we eliminate severe ovarian hyperstimulation syndrome?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176292

Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176292

Prediction of ovarian hyperstimulation syndrome. Challenging the estradiol mythos

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176292

Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176292

Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176292

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1757-2215-6-77

1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1757-2215-6-77

Ovarian hyperstimulation syndrome: a new insight into an old enigma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176292

Elimination of ovarian hyperstimulation syndrome

28 October 2018

1 reference

12 December 2020

Intensive luteal-phase support with oestradiol and progesterone after GnRH-agonist triggering: does it help?

1 reference

12 December 2020

Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient

1 reference

12 December 2020

Role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome

1 reference

12 December 2020

Etiology of OHSS and use of dopamine agonists

1 reference

12 December 2020

The possible role of intravenous immunoglobulin in preventing pre-eclampsia

1 reference

12 December 2020

Ovarian hyperstimulation syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1186/1757-2215-6-77

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference